Beacon Capital Management LLC (Tennessee)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.8K | Sell |
150
-31
| -17% | -$13.8K | 0.01% | 280 |
|
|
2025
Q1 | $87.8K | Buy |
181
+31
| +21% | +$15K | 0.01% | 222 |
|
|
2024
Q4 | $60.4K | Hold |
150
| – | – | 0.01% | 272 |
|
|
2024
Q3 | $69.8K | Buy |
150
+7
| +5% | +$3.26K | 0.01% | 262 |
|
|
2024
Q2 | $67K | Hold |
143
| – | – | 0.01% | 240 |
|
|
2024
Q1 | $59.8K | Sell |
143
-1
| -0.7% | -$418 | 0.01% | 260 |
|
|
2023
Q4 | $50.1K | Buy |
144
+143
| +14,300% | +$49.7K | 0.01% | 222 |
|
|
2023
Q3 | $352 | Hold |
1
| – | – | ﹤0.01% | 980 |
|
|
2023
Q2 | $352 | Hold |
1
| – | – | ﹤0.01% | 980 |
|
|
2023
Q1 | $315 | Hold |
1
| – | – | ﹤0.01% | 904 |
|
|
2022
Q4 | $289 | Hold |
1
| – | – | ﹤0.01% | 960 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 982 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 962 |
|
|
2022
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 962 |
|